We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

63 hedge funds and large institutions have $164M invested in iShares US Pharmaceuticals ETF in 2013 Q2 according to their latest regulatory filings, with 63 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

107.64% more ownership

Funds ownership: 0% → 107.64% (+108%)

Holders
63
Holders Change
+63
Holders Change %
–
% of All Funds
2.06%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
63
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
51
Barclays
United Kingdom
$68K +$68.4K +2,058 New
SF
52
Synovus Financial
Georgia
$63K +$62.6K +1,884 New
PNC Financial Services Group
53
PNC Financial Services Group
Pennsylvania
$40K +$39.9K +1,200 New
FHC
54
First Heartland Consultants
Missouri
$36K +$36.3K +1,092 New
Citigroup
55
Citigroup
New York
$35K +$35.4K +1,065 New
MFS
56
MSI Financial Services
Massachusetts
$33K +$33.1K +996 New
RIA
57
Regal Investment Advisors
Michigan
$30K +$29.8K +897 New
DSC
58
Duncker Streett & Co
Missouri
$30K +$29.9K +900 New
WTC
59
WhitTier Trust Company
Nevada
$25K +$24.9K +750 New
AFC
60
AFT Forsyth & Company
Florida
$20K +$19.9K +600 New
GI
61
Gradient Investments
Minnesota
$17K +$16.8K +507 New
HNB
62
Huntington National Bank
Ohio
$15K – – –
Envestnet Asset Management
63
Envestnet Asset Management
Illinois
$5K +$4.98K +150 New
BC
64
Bartlett & Co
Ohio
$3K +$2.99K +90 New
1 2
3

IHE Hedge Fund Activity: Q2 2013 in Review

63 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q2 2013, worth a combined $164M.

Buyers outnumbered sellers: 63 funds opened new IHE positions and 0 closed out — a net gain of 63 holders — while 0 added to existing stakes and 0 trimmed.

  • 63 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $164M of iShares US Pharmaceuticals ETF stock for Q2 2013.
  • 63 funds opened new iShares US Pharmaceuticals ETF positions in Q2 2013 and 0 closed out, a net change of +63 holders.

Based on aggregated 13F filings for Q2 2013.